Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Kunz Barbara Lopez, Director. Officer active across 1 company, notably Aptevo Therapeutics Inc.. In total, 6 disclosures have been published. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Barbara Lopez Kunz is a Board Member at Aptevo Therapeutics Inc. She participates in the governance of the company, contributing to strategic decision-making and the overall direction of the organization. Her experience in the biopharmaceutical sector is an asset for Aptevo in achieving its objectives.